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Francisella tularensis is a Gram-negative bacterium capable of causing the zoonotic disease 
tularaemia in a large number of mammalian species and in arthropods. F . tularensis is a facultative 
intracellular bacterium that infects and replicates in vivo mainly inside macrophages. During 
its systemic dissemination, F . tularensis must cope with very different life conditions (such as 
survival in different target organs or tissues and/or survival in the blood stream…) and may 
thus encounter a broad variety of carbon substrates, nitrogen, phosphor, and sulfur sources, 
as well as very low concentrations of essential ions. The development of recent genome-wide 
genetic screens have led to the identification of hundreds of genes participating to variable 
extents to Francisella virulence. Remarkably, an important proportion of the genes identified 
are related to metabolic and nutritional functions. However, the relationship between nutrition 
and the in vivo life cycle of F . tularensis is yet poorly understood. In this review, we will address 
the importance of metabolism and nutrition for F . tularensis pathogenesis, focusing specifically 
on amino acid and carbohydrate requirements.
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chronic infections. Notably, S. enterica, seems to undergo only 
limited replication cycles in SVCs. Although the nutritional con-
tent of SVCs is still poorly defined, transcriptomic and proteomic 
analyses have suggested that ions such as magnesium, manganese, 
and iron, could be limited in the SCV. Furthermore, in vivo studies 
have indicated that sugars, fatty acids, and acetate, could be used 
as carbon sources (García-del Portillo et al., 2008). Other intracel-
lular bacteria, like Francisella, Listeria, Shigella, and Rickettsia, have 
chosen the cytosol as a replication niche (Casadevall, 2008). The 
host cell cytosol is generally viewed as a more permissive milieu 
than the phagosomal compartment.
In this review, we shall try to understand the importance of 
metabolism and nutrition for F. tularensis pathogenesis, focusing 
specifically on amino acid and carbohydrate requirements.
F. tularensis nutritional requirements
Francisella tularensis is a Gram-negative bacterium capable of caus-
ing the zoonotic disease tularaemia in a large number of mammalian 
species and in arthropods such as ticks, flies, and mosquitoes (Keim 
et al., 2007). It is a highly infectious bacterium that can be transmit-
ted to humans in numerous ways, including contact with infected 
animals, inhalation, ingestion of contaminated water or food, or 
insect bites (Sjostedt, 2007). Four different subspecies (subsp.) of 
F. tularensis are generally recognized that differ in virulence and 
geographic distribution. These are four designated subsps. tularensis 
(type A), holarctica (type B), novicida, and mediasiatica, respectively. 
However, the classification of novicida as a subspecies is still a matter 
of debate (Huber et al., 2010; Johansson et al., 2010). F. tularensis 
subsp. tularensis is the most virulent subspecies causing a severe 
disease in humans, whereas F. tularensis subsp. holarctica causes a 
similar disease but of less severity (McLendon et al., 2006). Because 
of its high infectivity and lethality, F. tularensis is considered a poten-
tial bioterrorism agent (Oyston and Griffiths, 2009).
intracellular pathogens and metabolic 
requirements
The  in  vivo  metabolism  of  pathogenic  bacteria  constitutes  an 
important, and yet insufficiently studied, aspect of host–pathogen 
interactions. Metabolic pathways comprise: (i) degradative path-
ways (catabolism) of organic molecules, processes generally accom-
panied by the production of energy; and (ii) biosynthetic pathways 
(anabolism) that uses energy to build-up molecules. Both metabolic 
pathways require the sequential action of dedicated enzymes whose 
expression and activity may be tightly regulated in response to 
environmental changes. In order to survive and efficiently replicate 
in host cells, intracellular pathogens must adapt their metabolism 
to the available nutrients and physical conditions (including pH, 
oxygen availability, osmotic pressure, etc.). Metabolism is tightly 
associated with nutritional capacities, which involve nutrient avail-
ability and dedicated nutrient uptake systems. Indeed, pathogenic 
bacteria use the host organism as a macronutrient system that 
comprises many different specialized microenvironments. In par-
ticular, bacteria capable of systemic dissemination like Francisella 
tularensis have to cope with very different life conditions (such 
as survival in different target organs or tissues and/or survival in 
the blood stream, etc.) and may thus encounter a broad variety of 
carbon substrates, nitrogen, phosphor, and sulfur sources, as well 
as very low concentrations of essential ions such as magnesium, 
manganese, and iron (Eisenreich et al., 2010).
Many intracellular bacteria reside in a vesicular compartment 
(e.g., Salmonella, Legionella, Brucella, Mycobacteria, etc.). These 
bacteria encounter stressful conditions in these membrane-bound 
vacuoles (low pH, free-radicals, nutrient deprivation, antimicrobial 
compounds, etc.) and have therefore developed efficient defense 
mechanisms. For example, S. enterica is able to survive and replicate 
for extended periods in Salmonella-containing vacuoles (SVCs) 
of infected cells (preferentially macrophages) and thus can cause Frontiers in Microbiology  |  Cellular and Infection Microbiology    December 2010  | Volume 1  | Article 140  |  2
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The absolute requirement for growth of the other 12 amino acids 
contained in the medium has not been experimentally confirmed. 
Functional biosynthetic pathways have been identified in the Schu S4 
genome for the seven non-essential amino acids (alanine, asparag-
ine, glutamate, glycine, glutamine, phenylalanine, and tryptophan). 
Evidence was also found in the Schu S4 genome for biosynthetic 
pathways for 8 of the 13 amino acids that are supplied in the synthetic 
medium (see Table 1; Larsson et al., 2005). However, of these eight, 
the biosynthetic pathways for isoleucine, valine, and threonine are 
predicted to have missing steps and therefore to be non-functional 
(due to presence of pseudogenes encoding enzymes catalyzing the 
missing steps in the pathways). Altogether, the pathways for arginine, 
histidine, lysine, tyrosine, methionine, cysteine, threonine, valine, 
and isoleucine biosynthesis seem to be incomplete or absent. F. tula-
rensis subsp. tularensis strain Schu S4 is hence auxotroph for these 
amino acids. It remains to be determined whether one or more of 
the other four amino acids for which pathways were predicted to be 
present, but supplied by the synthetic medium (i.e., serine, aspartate, 
leucine, and proline), are absolutely required for growth.
aromatic amino acid biosynthetic pathways
The shikimate pathway (Figure 1) is the common pathway for the 
biosynthesis of chorismate, which is the precursor for the gen-
eration of aromatic amino acids, para-aminobenzoic acid (pABA, 
Francisella tularensis is a facultative intracellular bacterium that 
infects and replicates in vivo mainly inside macrophages, but which 
can also infect and survive in a variety of non-phagocytic mam-
malian cells such as hepatocytes, endothelial cells, epithelial cells, 
and fibroblasts (Santic et al., 2010). Remarkably, F. tularensis is 
also one of the rare bacteria that can survive within neutrophils 
(McCaffrey and Allen, 2006). F. tularensis subsp. holarctica live vac-
cine strain (LVS) has been shown to inhibit the respiratory burst by 
preventing NADPH oxidase assembly at the phagosomal membrane 
(McCaffrey and Allen, 2006). Attempts to identify LVS genes that 
affect neutrophil function have only led to the selection of uracil 
auxotrophs (carA, carB, and pyrB) whose intracellular growth defect 
are most likely pleiotropic.
Francisella tularensis strains, including highly virulent species, 
have also been reported to survive and multiply in amebae in the 
environment (Abd et al., 2003; El-Etr et al., 2009), suggesting a 
potential link between ameba–Francisella interactions and envi-
ronmental persistence. The specific nutritional requirements of 
F. tularensis sensu lato in the ameba have not yet been studied.
The recent availability of complete genome sequences and the 
development of numerous genome-scale genetic methods have led 
to the identification of hundreds of genes participating to variable 
extents to Francisella virulence (Ahlund et al., 2010; Akimana et al., 
2010; Asare and Abu Kwaik, 2010; Asare et al., 2010; Lai et al., 2010; 
Meibom and Charbit, 2010, and references therein; Moule et al., 
2010; Peng and Monack, 2010). However, the specific contribution 
of only a limited number of these genes is currently understood 
at the molecular level. Although an important proportion of the 
genes identified are related to metabolic and nutritional func-
tions, the relationship between nutrition and the in vivo life cycle 
of F. t  ularensis is yet poorly understood.
F. tularensis biosynthetic pathways and virulence
Let us first consider the general relationship between the presence 
or absence of a biosynthetic pathway and its associated nutritional 
requirement. By definition, in a synthetic (or minimal) medium, a 
prototrophic (heterotrophic) facultative intracellular bacterium is 
able to synthesize all its components from the carbohydrate source 
provided. When one or several genes of a biosynthetic pathway are 
missing, or have been inactivated, supplementation of the medium 
by the substrate is required for growth (the bacterium is auxotroph 
for this substrate). In infected cells, two outcomes exist when a bio-
synthetic pathway is impaired in a mutant strain: (i) if the mutant 
bacteria require supplementation of the medium by the cognate 
substrate for intracellular growth, it is deduced that the intracellular 
milieu is depleted (or limited) for that substrate; (ii) alternatively, if 
the mutant bacteria grow like the wild-type strain, this is deduced 
the intracellular milieu is replete in that substrate (and implies that 
the bacterium is able to take-up enough substrate for growth).
A chemically defined growth medium was developed to support 
the growth of F. tularensis, which includes 13 amino acids (Traub 
et al., 1955; Nagle et al., 1960). Later, Chamberlain optimized the 
concentrations of the different components (amino acids, vitamins, 
ions) of this medium that is still widely used (Chamberlain, 1965). 
F. tularensis strains Schu S4 (subsp. tularensis) and LVS (subsp. hol-
arctica) both require cysteine for growth, most likely due to a non-
functional pathway for sulfate assimilation (Larsson et al., 2005). 
Table 1 | Nutritional requirements of F. tularensis.
Amino acids  Biosynthetic  Pathway score* 
  pathway 
  predicted
RequiRed FoR gRowTh iN syNTheTic BRoTh
Arginine  No  –
Histidine  No  –
Lysine  No  –
Methionine  No  –
Tyrosine  No  –
Cysteine (incomplete/required)  Yes  5/3/3
Isoleucine (incomplete/required)  Yes  5/4/1
Threonine (incomplete/required)  Yes  2/1/0
Valine (incomplete/required)  Yes  4/3/2
Serine (required ?)  Yes  3/2/2
Aspartic acid (required ?)  Yes  1/1/1
Leucine (required ?)  Yes  4/2/0
Proline (required ?)  Yes  4/2/1
NoT RequiRed FoR gRowTh iN syNTheTic BRoTh
Alanine  Yes  3/2/2
Asparagine  Yes  2/1/0
Glutamate  Yes  1/1/1,1/1/1, 1/1/1
Glutamine  Yes  2/2/1
Glycine  Yes  2/1/1, 1/1/1
Phenylalanine  Yes  3/2/2,4/2/2, 3/2/2
Tryptophan  Yes  5/5/0
In the F . tularensis subsp. tularensis Schu S4 genome. Each predicted pathway, 
P , was assigned a score X/Y/Z, according to Larsson et al. (2005). P consists of X 
reactions; enzymes for Y reactions were identified in the genome; and Z of the Y 
reactions are used in other predicted pathways.www.frontiersin.org  December 2010  | Volume 1  | Article 140  |  3
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FiguRe 1 | The shikimate pathway. Genes that have been identified in genetic screens (in vivo or in vitro) are underlined. Genes that have not been hit in any 
screen are in blue. TrpD*, the gene is absent in the Schu S4 and LVS strains but present in the subsp. novicida (FTA_2078). TyrA*, the gene is absent in the Schu S4 
strain but present in both LVS (FTL_048) and subsp. novicida (FTN_0055).
folate biosynthesis), 2,3-dihydroxybenzoic acid (DHB, biosynthesis 
of siderophores), ubiquinone, and menaquinone (Bentley, 1990; 
Figure 1). Notably, F. tularensis sensu lato has been shown to express 
a siderophore under iron limiting conditions. This siderophore, 
structurally similar to rhizoferrin, promotes the growth of both 
LVS and Schu S4 strains under iron limitation. The siderophore 
locus, designated fsl in F. tularensis subsp. tularensis (Schu S4) and 
F. tularensis subsp. holarctica (LVS), or fig in F. tularensis subsp. novi-
cida, is involved in both synthesis and uptake of the siderophore. 
(Sullivan et al., 2006; Kiss et al., 2008; Ramakrishnan et al., 2008; 
Crosa et al., 2009).
Bruce Stocker’s pioneer work on the genetics of Salmonella 
enterica serovar Typhimurium (S. typhimurium) has demonstrated 
the crucial importance of the aromatic biosynthetic pathway for 
bacterial virulence. Mutations in different genes coding for the 
biosynthesis of aromatic amino acids have been used to reduce the 
virulence of Salmonella strains and for immunization of various 
animal species (Chatfield et al., 1994, 1995). The attenuation of 
aro mutants of S. typhimurium is thought to be due to the inability 
of the bacterium to generate pABA and DHB from chorismate 
(Hoiseth and Stocker, 1981). Remarkably, aroA and aroD mutants 
of S. enterica serovar Typhi were also successfully tested as a vaccine 
against human typhoid (Tacket and Levine, 2007).
All of the necessary genes encoding the chorismate pathway 
enzymes are present in the genome of F. tularensis Schu S4 (i.e., aroG, 
aroB, aroD, aroE, aroK, aroA, and aroC). The genes (pabA and pabB) 
encoding the two components of para-aminobenzoate synthase have 
also been identified in the F. tularensis Schu S4 genome as well as the 
gene encoding FolP, FolC, and FolA, involved in folate biosynthesis. 
In recent screens, we and others (Su et al., 2007; Alkhuder et al., 
2009) have selected mutants in gene FTL_1240 (aroG), encoding 
DAHP synthase. This is the first enzyme of the aromatic amino 
acid biosynthetic pathway, which converts erythro-4-phosphate and 
phosphoenolpyruvate (PEP) to 3-deoxy-d-arabino-  heptuosonate-
7-phosphate. We have shown that an aroG mutant of LVS had only a 
slightly reduced intracellular growth capacity, in both J774 cells and 
in bone marrow-derived macrophages (BMM). Still, in the mouse 
model, the mutant strain was very severely attenuated. Of interest, 
wild-type Escherichia coli has been shown to produce three feedback 
inhibitor-sensitive DAHP synthase isoenzymes: a tyrosine-sensi-
tive, a phenylalanine-sensitive, and a tryptophan-sensitive enzyme 
(encoded by genes genes aroF, aroG, and aroH, respectively). Hence, 
the functionality of a biosynthetic pathway does not only depend 
on the presence of intact genes but may also rely on the amount 
and activity of the enzymes.
This interplay between the availability of an amino acid and the 
activity of its cognate biosynthetic pathway might exist for other 
types of nutrients that the bacterium can either biosynthesize or 
acquire from its growth medium.
Additional genes of the F. tularensis aromatic amino acid bio-
synthetic pathway have been identified in genome-wide screens: 
aroA, aroB, aroC, aroE1, tyrA, trpA, trpB, trpC, and trpE. The gene Frontiers in Microbiology  |  Cellular and Infection Microbiology    December 2010  | Volume 1  | Article 140  |  4
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aroA is responsible for the sixth step of the biosynthetic pathway 
(converting shikimate-3-phosphate and PEP to 5-enolpyruvyl-
shikimate-3-phosphate). An aroA mutant of F. tularensis Schu S4 
strain was selected in a screen of transposon insertion mutants 
performed in the human hepatic carcinoma cell line HepG2 (Qin 
and Mann, 2006). The same screen also led to the identification of 
purine and pyrimidine auxotrophs (see below).
An aroB mutant of F. tularensis subsp. novicida (FTN_1135), 
encoding a putative 3-dehydroquinate synthetase, has been very 
recently identified in a screen in human macrophages (Asare and 
Abu Kwaik, 2010). The mutant strain, which was also deficient for 
growth in Drosophila melanogaster-derived S2 cells, localized to the 
cytosol in macrophages, indicating a cytosolic growth defect.
The gene aroC encodes chorismate synthase, the seventh step 
of the aromatic biosynthetic pathway. It was identified in a screen 
of transposon insertion mutants performed in F. tularensis subsp. 
novicida, searching for genes required for pulmonary and systemic 
infection in mice (Kraemer et al., 2009). The gene tyrA (FTN_0055), 
which encodes the enzyme prephenate dehydrogenase converting 
chorismate to tyrosine, was also hit in this in vivo screen, as was 
aroC. Notably, the tyrA gene is absent in the Schu S4 strain but 
present in LVS (FTL_0048). aroC encodes the enzyme performing 
the last step of chorismic acid synthesis. The gene aroE1, which 
encodes shikimate-5-dehydrogenase, the fourth step of the biosyn-
thetic pathway, was identified in two screens of transposon inser-
tion mutants. One screen was performed in F. tularensis subsp. 
holarctica LVS searching for auxotrophic mutants unable to grow 
on chemically defined medium (Maier et al., 2006) and the other 
was a screen of F. tularensis subsp. novicida for mutants unable to 
replicate intracellularly in macrophages (Asare and Abu Kwaik, 
2010). Finally, five genes (trpA, trpB, trpC, trpE, and trpG1) encod-
ing enzymes involved in the conversion of chorismic acid to tryp-
tophan were identified in three in vivo selections using F. tularensis 
subsp. novicida (Weiss et al., 2007; Kraemer et al., 2009; Peng and 
Monack, 2010).
Altogether,  almost  every  gene  in  the  aromatic  amino  acids 
biosynthetic pathway has been identified in mutant screens, high-
lighting the importance this pathway for F. tularensis virulence. 
Interestingly, several of the genes have also been found to be impor-
tant for growth/virulence in a non-mammalian model, in vivo in 
D. melanogaster or in vitro in D. melanogaster-derived cells (Asare 
et al., 2010; Moule et al., 2010).
Purine and pyrimidine biosynthetic pathways
In silico analysis reveals that the F. tularensis genomes encode all 
the enzymes necessary for the de novo synthesis of purines and 
pyrimidines. The two pathways are virtually identical to those in 
E. coli.
Pur pathway. Several  pur  auxotrophic  mutants  of  F.  tularensis 
(Figure 2), selected from banks of mutants or genetically engineered, 
have already been obtained and tested for virulence (Gray et al., 
2002; Qin and Mann, 2006; Tempel et al., 2006; Quarry et al., 2007; 
Titball et al., 2007; Weiss et al., 2007; Kadzhaev et al., 2009; Asare and 
Abu Kwaik, 2010; Asare et al., 2010; Peng and Monack, 2010). The 
pur mutants with single gene mutations showed variable degrees of 
attenuation in vivo and growth defects in vitro, suggesting that the 
step at which the pathway is inactivated may have a distinct impact 
FiguRe 2 | The purine biosynthetic pathway. Genes that have been identified in genetic screens (in vivo or in vitro) are underlined. Genes that have not been hit in 
any screen are in blue.www.frontiersin.org  December 2010  | Volume 1  | Article 140  |  5
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on virulence. Remarkably, Pechous et al. showed that a triple mutant 
∆purMCD in both LVS (Pechous et al., 2006) and Schu S4 (Pechous 
et al., 2008) strains led to severe intracellular growth defects and 
strong attenuation in the mouse model. The fact that inability of 
these strains to synthesize purines de novo leads to a severe intracel-
lular growth defect supports the notion that macrophages contain 
limiting concentrations of purines (Appelberg, 2006).
Pyr pathway. The pathway converting l-glutamine to uridine mono-
phosphate (UMP) comprises six steps (Figure 3). Several mutants 
in this pathway have been identified in genetic screens (Qin and 
Mann, 2006; Weiss et al., 2007; Schulert et al., 2009; Asare and Abu 
Kwaik, 2010; Peng and Monack, 2010). Mutants unable to perform 
the first step, i.e., bacteria with mutations in genes carA or carB 
(encoding the two subunits of carbamoyl phosphate synthetase, 
converting l-glutamine to carbamoyl-P) were severely impaired in 
intramacrophage growth. However, conflicting results were reported 
regarding the phenotype of pyrB mutants. On one hand, a pyrB 
transposon insertion mutant of Schu S4 (Qin and Mann, 2006) 
showed reduced growth in HepG2 hepatocytes but normal growth 
in J774 cells, and was attenuated in mice and a similar mutant in 
subsp. novicida was shown to have a growth defect in human mac-
rophages (Asare and Abu Kwaik, 2010). In contrast, another recent 
study (Kadzhaev et al., 2009) reports that a pyrB deletion mutant of 
Schu S4 is barely attenuated. In addition, mutants with transposon 
insertions in the carA, carB, and pyrB genes were selected upon 
screening of a bank of transposon mutants in LVS for mutants that 
failed to prevent the oxidative burst (Schulert et al., 2009). The three 
mutants appeared to grow normally in HepG2 and J774 cells but 
were killed by human monocytes and monocyte-derived macro-
phages. Transposon mutants of subsp. novicida with insertions in 
pyrF (encoding orotidine-5P decarboxylase, converting orotidine-5P 
to UMP) were identified in two in vivo screens (Weiss et al., 2007; 
Peng and Monack, 2010) and recently, a pyrF deletion mutant was 
generated in both F. tularensis subsp. holarctica (LVS) and tularensis 
(Schu S4). These F. tularensis ∆pyrF mutants were unable to replicate 
in primary human macrophages but retained full virulence in the 
mouse model (Horzempa et al., 2010).
These data clearly indicate that defects in the pyrimidine bio-
synthetic pathway affect Francisella virulence in a cell type- and 
strain-specific manner and suggest that in vivo the pyr pathway is 
not as important as the pur pathway for F. tularensis virulence.
F. tularensis carbon metabolism and virulence
Each intracellular pathogen has adapted its intracellular metabolism 
to the nutrient supply of the host cell. Nevertheless, two bacterial 
species using the same host cell compartment (facing thus the same 
nutritional environment) may have quite different preferred carbon 
sources (and hence carbon metabolisms). Carbon catabolism pro-
vides the bacterial cell with energy and essential biosynthetic pre-
cursors such as glucose-6-phosphate (G6-P), fructose-6-phosphate 
(F6-P), 3-phosphoglycerate, PEP, and acetyl-CoA.
Glycolysis and gluconeogenesis pathways
Hexoses such as glucose are the preferred carbon and energy sources 
for many bacteria. The three best-characterized pathways of sugar 
catabolism in bacteria are glycolysis (Figure 4), the pentose phos-
phate pathway and the Entner–Doudoroff pathway. Each of these 
different pathways can be the preferred, or exclusive, carbon uti-
lization pathway in a given pathogenic bacterial species. In the 
following we will discuss only genes encoding enzymes in glyco-
lysis (and gluconeogenesis) and shown in Figure 4 and not other 
carbohydrate metabolism pathways.
pckA. The enzyme PEP carboxykinase, encoded by the gene pckA, 
catalyzes the conversion of oxaloacetate to PEP. In Mycobacterium 
bovis BCG, a pckA mutant is attenuated both in vitro and in vivo 
(Liu et al., 2003), while this gene is dispensable in Salmonella 
(Tchawa Yimga et al., 2006). In F. tularensis subsp. tularensis Schu 
S4, Kadzhaev et al. (2009) observed no attenuation of a ∆pckA 
mutant in mice. The biological activity of this enzyme has not been 
experimentally established.
glpX. The glycolytic and gluconeogenic pathways comprise essen-
tially the same set of enzymes that catalyze reversible reactions, 
except between F6-P and fructose-1,6-bisphosphate (F1,6-P2). The 
glycolytic reaction leading to the production of F1,6-P2 is cata-
lyzed by phosphofructokinase, while the gluconeogenic reaction 
FiguRe 3 | The pyrimydine biosynthetic pathway. Genes that have been 
identified in genetic screens (in vivo or in vitro) are underlined. Genes that 
have not been hit in any screen are in blue.Frontiers in Microbiology  |  Cellular and Infection Microbiology    December 2010  | Volume 1  | Article 140  |  6
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The intracellular transcriptome of F. tularensis reveals that a 
number of genes involved in carbohydrate metabolism were up-
regulated in BMM (Wehrly et al., 2009). In particular, genes of the 
glycolytic/gluconeogenic pathway have been found (pgm, glk, fbaB, 
and pgk; Figure 4), suggesting that this pathway is used during 
intracellular growth.
Very recently, a systems biology approach was applied to iden-
tify F. tularensis metabolic networks (Raghunathan et al., 2010). 
Integration of in silico metabolic reconstitutions and experimental 
data (including metabolic profiling and transcriptomic analyses) 
suggested that significant changes in carbohydrate metabolism 
occur  during  the  intracellular  growth  phase.  Gene  expression 
profiling further supported the prediction that F. tularensis pref-
erentially utilizes specific amino acids for energy and fatty acids 
as gluconeogenic substrates rather than relying on carbohydrate 
sources like glucose and fructose during infection.
nutrient uptake systems of F. tularensis
Intracellular  bacteria  must  possess  dedicated  nutrient  uptake 
systems to capture their necessary host-derived nutrients. These 
systems must be particularly efficient for substrates available in 
limiting concentrations. The majority of the predicted transport 
systems present in F. tularensis are secondary carriers (Table 2). 
Secondary transporters encompass several major families, includ-
ing: (i) the major facilitator superfamily (MFS, 31 proteins), pre-
dicted to participate in various functions including drug efflux, 
amino acids and sugar uptake; (ii) the amino acid-polyamine-
organocation transporters (APC, 11 proteins); (iii) the hydroxy/
aromatic amino acid permeases (HAAAP, 7 proteins); and (iv) the 
proton-dependent oligopeptide transporters (POT, 8 proteins). 
  yielding F6P is catalyzed by fructose-1,6-bisphosphatase (FBP). 
The F. tularensis subsp. tularensis Schu S4 genome encodes appar-
ently only a FBP (encoded by glpX) and lacks a pfkA gene encod-
ing phosphofructokinase (Raghunathan et al., 2010). This suggests 
that F. tularensis uses the Embden–Meyerhof–Parnas pathway for 
gluconeogenesis rather than for glycolysis. However, the exact bio-
logical activity of the FBP enzyme remains to be experimentally 
established in F. tularensis. Mutants in the glpX gene have been 
repeatedly obtained in genetic screens, in vivo as well as in vitro 
(Maier et al., 2007; Su et al., 2007; Weiss et al., 2007; Kraemer et al., 
2009; Peng and Monack, 2010). Moreover, a glpX deletion mutant 
of F. tularensis subsp. tularensis Schu S4 has been shown recently 
to be almost avirulent in the mouse model (Kadzhaev et al., 2009). 
Altogether, these observations strongly suggest that gluconeogen-
esis is critical for the full virulence of F. tularensis. At this stage, it 
cannot be excluded that the virulence defect of the glpX mutant 
could be due to another function of this enzyme, possibly regula-
tory. Supporting this hypothesis, none of the other genes involved 
in the conversion of glucose to PEP has been identified in previous 
genetic screens, but it is possible that some of these (pgi, gpmI, 
eno) are essential genes and therefore will not be found in screens 
(Gallagher et al., 2007). It remains to be determined by a systematic 
mutagenesis approach whether other enzymes in this pathway may 
also be involved in virulence.
pgm. The pgm gene encodes a predicted phosphoglucomutase, 
a glyconeogenic enzyme involved in the reversible conversion of 
glucose-1-phosphate (G1-P) to G6-P. A mutant in the pgm gene 
has been identified after an in vivo genetic screen in the F. tularensis 
subsp. novicida (Weiss et al., 2007).
FiguRe 4 | The glycolytic and gluconeogenic pathways. GlpX is the only 
enzyme not promoting a reversible reaction. Genes that have been identified in 
genetic screens (in vivo or in vitro) are underlined. Genes that have not been hit 
in any screen are in blue. Genes predicted to be essential (according to 
Gallagher et al., 2007) are in red. The black dotted arrows indicate the connection 
between the glycolytic/gluconeogenic pathways and the pentose phosphate 
and fructose pathways. In each pathway, the gene name is indicated to the left 
of each reaction and the corresponding FTT number, to the right.www.frontiersin.org  December 2010  | Volume 1  | Article 140  |  7
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Table 2 | The transport systems of F. tularensis.
oRF Family ida substrate experimental datab
ioN chANNels
FTT0685c VIC Potassium ion channel Identified screen (Weiss et al., 2007)
FTT1775c ClC Chloride ion channel –
FTT0475 MscS Mechanosensitive channel Identified screen (Asare et al., 2010)
FTT0992 MscS Mechanosensitive channel Identified screen (Asare et al., 2010)
FTT0133 MIP Glycerol uptake –
FTT1342 LIC Glutamate-gated chloride channel Identified screen (Asare and Abu Kwaik, 2010)
Down-regulated in cells (Wehrly et al., 2009)
secoNdARy TRANsPoRTeRs
FTT0006 MFS Proline/betaine –
FTT0026c MFS Drug efflux, Iron transport Identified screen (Asare et al., 2010)
Up-regulated in cells (Wehrly et al., 2009)
FTT0028c MFS Multidrug efflux, Iron transport Identified screen (Weiss et al., 2007; Asare et al., 2010; Moule et al., 2010)
Up-regulated in cells (Wehrly et al., 2009)
FTT0053 MFS ? Identified screen (Maier et al., 2007; Weiss et al., 2007; Moule et al., 2010)
FTT0056c MFS ? Identified screen (Qin and Mann, 2006; Weiss et al., 2007; Moule et al., 2010; 
Peng and Monack, 2010)
FTT0070c MFS AmpG homolog MglA regulated (Brotcke et al., 2006)
FTT0104c MFS ? Identified screen (Kraemer et al., 2009; Asare and Abu Kwaik, 2010)
FTT0127c MFS Multidrug efflux? Identified screen (Kraemer et al., 2009)
FTT0129 MFS ? Identified screen (Qin and Mann, 2006; Asare et al., 2010)
FTT0164c MFS Bicyclomycin efflux Identified screen (Asare et al., 2010)
FTT0280c MFS Multidrug efflux? –
FTT0442c MFS Bicyclomycin efflux Down-regulated in cells (Wehrly et al., 2009)
FTT0444 MFS Tetracycline efflux Identified screen (Su et al., 2007)
FTT0488c MFS ? Identified screen (Asare et al., 2010)
Down-regulated in cells (Wehrly et al., 2009)
FTT0671 MFS ? –
FTT0708 MFS ? Identified screen (Su et al., 2007; Asare et al., 2010)
Up-regulated in cells (Wehrly et al., 2009)
FTT0719 MFS Proline/betaine Identified screen (Asare et al., 2010)
FTT0725c MFS Glycerol-3-phosphate Identified screen (Asare and Abu Kwaik, 2010)
FTT0804 MFS Proline/betaine Down-regulated in cells (Wehrly et al., 2009)
FTT0931 MFS Glucose/galactose –
FTT0995 MFS Proline/betaine Identified screen (Asare et al., 2010; Moule et al., 2010)
FTT1148c MFS ? –
FTT1196c MFS Proline/betaine Identified screen (Peng and Monack, 2010)
FTT1256 MFS Multidrug efflux Identified screen (Asare et al., 2010)
Down-regulated in cells (Wehrly et al., 2009)
FTT1291 MFS d-Galactonate –
FTT1311 MFS Multidrug efflux Identified screen (Moule et al., 2010)
FTT1473c MFS Galactose/proton symport Identified screen (Asare et al., 2010)
FTT1474c MFS Galactose/proton symport Identified screen (Asare and Abu Kwaik, 2010)
FTT1683c MFS Multidrug efflux –
FTT1727c MFS Chloramphenicol efflux Down-regulated in cells (Wehrly et al., 2009)
FTT1783 MFS Proline/betaine Identified screen (Moule et al., 2010)
FTT0446 POT Dipeptide/tripeptide/oligopeptide Identified screen (Tempel et al., 2006)
Down-regulated in cells (Wehrly et al., 2009)
FTT0572 POT Dipeptide/tripeptide/oligopeptide Up-regulated in cells (Wehrly et al., 2009)
FTT0651 POT Dipeptide/tripeptide/oligopeptide MglA-regulated (Brotcke et al., 2006)
(Continued)Frontiers in Microbiology  |  Cellular and Infection Microbiology    December 2010  | Volume 1  | Article 140  |  8
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FTT0686c POT Dipeptide/tripeptide/oligopeptide Identified screen (Asare and Abu Kwaik, 2010)
Up-regulated in cells (Wehrly et al., 2009)
FTT0953c POT Dipeptide/tripeptide/oligopeptide Up-regulated cells (Wehrly et al., 2009)
FTT1005c POT Dipeptide/tripeptide/oligopeptide Identified screen (Asare and Abu Kwaik, 2010; Moule et al., 2010)
FTT1233c POT Dipeptide/tripeptide/oligopeptide –
FTT1253 POT Dipeptide/tripeptide/oligopeptide Identified screen (Kraemer et al., 2009)
Up-regulated in cells (Wehrly et al., 2009)
FTT0219c PiT Phosphate –
FTT1630c SSS Sodium ion/proline Identified screen (Kraemer et al., 2009; Asare and Abu Kwaik, 2010)
FTT0598c DAACS Sodium ion/dicarboxylate Up-regulated in cells (Wehrly et al., 2009)
FTT1337c DAACS C4-dicarboxylate Identified screen (Asare et al., 2010)
FTT0849 BASS Sodium ion/bile acid Identified screen (Asare et al., 2010)
FTT0310 APC Amino acid MglA-regulated (Brotcke et al., 2006)
FTT0361c APC Glutamate/γ-aminobutyrate Identified screen (Kraemer et al., 2009; Asare et al., 2010)
FTT0480c APC Glutamate/γ-aminobutyrate Identified screen (Maier et al., 2007; Weiss et al., 2007; Kraemer et al., 2009; 
Peng and Monack, 2010)
FTT0881c APC Amino acid Identified screen (Su et al., 2007)
FTT0968c APC Amino acid Identified screen (Weiss et al., 2007; Su et al., 2007; Ahlund et al., 2010; 
Moule et al., 2010; Peng and Monack, 2010)
FTT0979c APC Amino acid –
FTT1020c APC Amino acid Identified screen (Moule et al., 2010)
FTT1149c APC Amino acid Identified screen (Asare et al., 2010)
Mutant constructed (Kadzhaev et al., 2009)
FTT1520c APC Glutamate/γ-aminobutyrate –
FTT1633c APC Lysine Identified screen (Weiss et al., 2007; Peng and Monack, 2010)
FTT1730c APC Amino acid –
FTT1760 NhaA Sodium ion/proton Identified screen (Asare et al., 2010)
FTT0268 CPA1 Sodium ion/proton Identified screen (Alkhuder et al., 2009; Kraemer et al., 2009)
FTT0604 CPA1 Sodium ion/proton –
FTT1490 CPA1 Sodium ion/proton Identified screen (Qin and Mann, 2006; Maier et al., 2007; Weiss et al., 2007; 
Moule et al., 2010)
FTT0669 CPA2 Potassium ion efflux –
FTT1638 Trk Potassium ion uptake Identified screen (Alkhuder et al., 2010)
FTT0756 CDF Cation efflux Identified screen (Weiss et al., 2007; Asare and Abu Kwaik, 2010)
FTT0885 CDF Cation efflux –
FTT0827c NCS2 Xanthine/uracil –
FTT0115 CNT Nucleosides Identified screen (Moule et al., 2010)
FTT0116 CNT Nucleosides Identified screen (Moule et al., 2010)
FTT0712c HAAAP Serine Identified screen (Weiss et al., 2007; Asare and Abu Kwaik, 2010)
FTT1126 HAAAP Aromatic amino acid –
FTT1502 HAAAP Tyrosine –
FTT1510c HAAAP Tyrosine –
FTT1668 HAAAP Serine Identified screen (Asare and Abu Kwaik, 2010)
FTT1688 HAAAP Tyrosine Identified screen (Maier et al., 2007; Weiss et al., 2007; Asare et al., 2010)
FTT1732c HAAAP Tyrosine Identified screen (Asare and Abu Kwaik, 2010)
FTT0853 ArsB Arsenite (ArsB) –
FTT1339c SulP Sulfate –
FTT0105c RND Multidrug efflux Identified screen (Su et al., 2007)
Mutant constructed (Bina et al., 2008)
FTT1115c RND Protein-export (SecDF) –
Table 2 | continued
oRF Family ida substrate experimental datab
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FTT1114c RND Protein-export (SecDF) –
FTT1728 NhaD Sodium ion/proton Identified screen (Asare et al., 2010)
FTT0368c MOP Virulence factor MviN Identified screen (Asare et al., 2010)
FTT1332 MOP Polysaccharide –
FTT1453c MOP O-antigen –
FTT0157c DMT Choline uptake (LicB) –
FTT0759 DMT Drug/metabolite? Identified screen (Su et al., 2007)
FTT1004c DMT Drug/metabolite? Identified screen (Asare et al., 2010)
FTT1118c DMT Drug/metabolite? Identified screen (Kraemer et al., 2009; Asare and Abu Kwaik, 2010)
FTT1399 DMT Drug/metabolite? Down-regulated in cells (Wehrly et al., 2009)
FTT1511 DMT Drug/metabolite? –
FTT1787c LysE Lysine efflux –
FTT1431 RhtB Threonine efflux –
FTT0829c AAE Aspartate/alanine Identified screen (Kraemer et al., 2009; Moule et al., 2010)
FTT0233c Oxa1 OxaA homolog Down-regulated in cells (Wehrly et al., 2009)
ATP-dePeNdeNT
FTT0109 ABC Lipid A export –
FTT0126 ABC Oligopeptide –
FTT0125 ABC Oligopeptide Mutant constructed, not attenuated (Kadzhaev et al., 2009)
MglA-regulated (Brotcke et al., 2006)
FTT0175c ABC Nitrate/sulfonate/taurine Identified screen (Asare et al., 2010)
Up-regulated in cells (Wehrly et al., 2009)
FTT0265 ABC Nitrate/sulfonate/taurine –
FTT0266 ABC Nitrate/sulfonate/taurine Identified screen (Asare and Abu Kwaik, 2010)
FTT0209c ABC Manganese/zinc ion Identified screen (Su et al., 2007; Asare et al., 2010)
Up-regulated in cells (Wehrly et al., 2009)
FTT0208c ABC Manganese/zinc ion Identified screen (Asare and Abu Kwaik, 2010)
FTT0207c ABC Manganese/zinc ion –
FTT0405 ABC Lipoprotein releasing Identified screen (Weiss et al., 2007)
FTT0404 ABC Lipoprotein releasing Down-regulated in cells (Wehrly et al., 2009)
FTT0481 ABC Putrescine –
FTT0564 ABC Putrescine Identified screen (Kraemer et al., 2009)
FTT0563 ABC Putrescine –
FTT0562 ABC Putrescine Identified screen (Asare and Abu Kwaik, 2010)
FTT0728 ABC Multidrug –
FTT0729 ABC Multidrug –
FTT0793 ABC Multidrug Identified screen (Weiss et al., 2007; Asare and Abu Kwaik, 2010;  
Peng and Monack, 2010)
FTT0972 ABC ? (Fe–S assembly/SufBCD 
system)
–
FTT0971 ABC ? (Fe–S assembly/SufBCD 
system)
–
FTT0973 ABC ? (Fe–S assembly/SufBCD 
system)
Identified screen (Kraemer et al., 2009)
FTT1024c ABC ? (YhbG) –
FTT1125 ABC d-Methionine Identified screen (Maier et al., 2007; Su et al., 2007; Kraemer et al., 2009; 
Asare et al., 2010)
Up-regulated in cells (Wehrly et al., 2009)
FTT1124 ABC d-Methionine Identified screen (Maier et al., 2007)
Up-regulated in cells (Wehrly et al., 2009)
Table 2 | continued
oRF Family ida substrate experimental datab
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FTT1248 ABC ? Identified screen (Asare et al., 2010)
FTT1247 ABC ? –
FTT1608 ABC Toluene tolerance –
FTT1249 ABC Toluene tolerance Identified screen (Moule et al., 2010)
FTT1611 ABC Toluene tolerance Identified screen (Su et al., 2007; Asare et al., 2010)
FTT1609 ABC Toluene tolerance –
FTT1335 ABC CydC/CydD homolog –
FTT1336 ABC CydC/CydD homolog –
FTT1435c ABC Multidrug? –
FTT1434c ABC Multidrug? Identified screen
FTT1782c ABC ?  Identified screen (Su et al., 2007; Weiss et al., 2007; Moule et al., 2010)
FTT0060 F-ATPase Protons –
FTT0064 F-ATPase Protons –
FTT0059 F-ATPase Protons –
FTT0063 F-ATPase Protons –
FTT0058 F-ATPase Protons –
FTT0062 F-ATPase Protons –
FTT0061 F-ATPase Protons Identified screen (Peng and Monack, 2010)
FTT0065 F-ATPase Protons Identified screen (Kraemer et al., 2009)
FTT1737c P-ATPase Potassium ion Identified screen (Asare and Abu Kwaik, 2010; Moule et al., 2010)
FTT1738c P-ATPase Potassium ion Identified screen (Asare et al., 2010)
FTT0120 IISP SRP receptor FtsY Identified screen (Moule et al., 2010)
FTT0964c IISP SRP protein Ffh –
PTS
FTT1280c SSPTS Nitrogen regulatory –
uNclAssiFied
FTT0668 PnuC Nicotinamide mononucleotide Identified screen (Asare et al., 2010; Moule et al., 2010)
Up-regulated in cells (Wehrly et al., 2009)
FTT0707 PnuC Nicotinamide mononucleotide –
FTT1090 PnuC Nicotinamide mononucleotide MlgA-regulated (Brotcke et al., 2006)
FTT0249 FeoB Ferrous ion Identified screen (Su et al., 2007; Ahlund et al., 2010)
aTransport family names: MFS, major facilitator superfamily; VIC, voltage-gated ion channel superfamily; ClC, chloride channel family; MscS, small conductance 
mechanosensitive ion channel; MIP , major intrinsic protein family; LIC, ligand-gated ion channel; POT, proton-dependent oligopeptide transporter family; PiT, inorganic 
phosphate transporter family; SSS, solute:sodium symporter family; DAACS, dicarboxylate/amino acid:cation (Na+ or H+) symporter family; BASS, bile acid:Na+ 
symporter family; APC, amino acid-polyamine-organocation family; NhaA, NhaA Na+:H+ antiporter family; CPA1, monovalent cation:proton antiporter-1 family; Trk, 
K+ transporter family; CDF , cation diffusion facilitator family; NCS2, nucleobase:cation symporter-2 family; CNT, concentrative nucleoside transporter family; HAAAP , 
hydroxy/aromatic amino acid permease family; ArsB, arsenite–antimonite efflux family; SulP , sulfate permease family; RND, resistance-nodulation-cell division 
superfamily; NhaD, NhaD Na+:H+ antiporter family; MOP , multidrug/oligosaccharidyl-lipid/polysaccharide flippase superfamily; DMT, drug/metabolite transporter 
superfamily; LysE, l-lysine exporter family; RhtB, resistance to homoserine/threonine family; AAE, aspartate:alanine exchanger family; oxa1, cytochrome oxidase 
biogenesis family; ABC, ATP-binding cassette superfamily; F-ATPase, H+- or Na+-translocating F-type, V-type and A-type ATPase superfamily; P-ATPase, P-type 
ATPase superfamily; IISP , type II (General) secretory pathway family; SSPTS, sugar specific PTS; PnuC, nicotinamide mononucleotide (NMN) uptake permease 
family; FeoB, ferrous iron uptake family.
bFor each putative transporter it is indicated if the encoding gene has been identified in a cell-based or in vivo screen, is regulated by the major virulence regulator 
MglA, or has a changed expression after entry into macrophages.
Table 2 | continued
oRF Family ida substrate experimental datab
Several mutants in secondary transporters were identified in vari-
ous genetic screens. For example, the gene xasA, encoding a pre-
dicted glutamate/γ-aminobutyrate transporter of the APC family 
(FTT_0480c, Table 2), has been identified in four different screens 
(Maier et al., 2007; Weiss et al., 2007; Kraemer et al., 2009; Peng 
and Monack, 2010), supporting a functional role in F. tularensis 
virulence. The gene FTT_0708, encoding a transporter of the MFS 
family has also been identified in an in vivo screen (Su et al., 2007), 
as were other transporters of this family.
The F. tularensis subsp. tularensis Schu S4 genome also encodes 15 
complete transport ABC-type carriers, consisting of a membrane-
spanning permease and an ATP-binding subunit (Atkins et al., 2006). 
These ABC transporters are predicted to participate in diverse func-
tions, ranging from amino acid/peptide and ion uptake to multidrug 
efflux. Remarkably, mutants in one ABC transporter (FTT_1125) 
have been identified in several in vitro (Maier et al., 2007) and in vivo 
(Su et al., 2007; Kraemer et al., 2009) screens for attenuated mutants, 
indicating a direct contribution to F. tularensis virulence.www.frontiersin.org  December 2010  | Volume 1  | Article 140  |  11
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Supporting a role of transport systems in intracellular survival, 
transcriptional profiling of the F. tularensis subsp. tularensis Schu S4 
strain in BMMs (Wehrly et al., 2009) revealed that genes encoding 
various transporters showed significantly altered expression (either 
up- or down-regulated) after host cell entry. Notably, five of the 
eight POT family members were up-regulated intracellularly. The 
amino acid identity between the POT family members does not 
exceed 47% (ranging from 22 to 31%, in most cases), suggesting 
that they might have distinct transport properties. Also, four of the 
POT transporters have been found in mutant screens (Tempel et al., 
2006; Kraemer et al., 2009; Asare and Abu Kwaik, 2010), further 
indicating that these oligopeptide transporters and therefore amino 
acid metabolism is important during infection.
In addition, the F. tularensis subsp. tularensis Schu S4 genome 
encodes  six  putative  ion  channels  but  is  devoid  of  any  PEP-
dependent phosphotransferase (PTS) system. At present, no bio-
chemical data are available on any of the transporters present in 
F. tularensis.
One example of amino acid supply provided by the host cytosol
The  cytosol  of  eukaryotic  cells  contains  a  high  concentration 
(10 mM) of the tripeptide γ-glu-gly-cys named glutathione (in its 
reduced form, GSH; Alkhuder et al., 2009). GSH plays a pleiotropic 
and major role in mammalian cell homeostasis and GSH-deficiency 
has been associated with various severe diseases (Griffith, 1999; Wu 
et al., 2004; Franco et al., 2007). Biosynthesis of GSH is dependent 
on the availability of the amino acid precursors glutamate, glycine, 
and cysteine. The intracellular pool of cysteine is relatively small 
(0.10–0.25 mM) and cysteine is generally the limiting amino acid 
for GSH synthesis. The other two precursors, glycine and gluta-
mate, are found in considerable higher intracellular concentra-
tion. As mentioned earlier, F. tularensis subspecies requires cysteine 
for growth. We have recently demonstrated that gene FTL_0766 
encodes a genuine γ-glutamyl transpeptidase (GGT) involved in 
the metabolism of γ-glutamyl-containing peptides. GGT allows 
the utilization of γ-glutamyl peptides as a source of cysteine dur-
ing intracellular multiplication of the F. tularensis subsp. holarctica 
strain LVS, and is thus critical for its virulence (Alkhuder et al., 
2009). This work represents the only direct experimental evidence 
of nutrient utilization by intracellular F. tularensis. The transporter 
of GSH and the molecular mechanism of crossing the bacterial 
envelope remain to be discovered.
starving the invading bacteria as a host cell 
defense mechanism
The capacity of a macrophage to deprive intracellular pathogens of 
required nutrients (Appelberg, 2006) can be viewed as an intrinsic 
antimicrobial innate immune defense mechanism. Thus, microbial 
killing may not rely only on a toxic environment (such as low pH 
and oxidative stress in the phagosomal compartment) but also may 
result from the scarcity of nutrients in the cellular compartment it 
occupies (transiently or permanently). At any rate, one must keep 
in mind that the notion of a limiting concentration of nutrient may 
vary considerable from one intracellular pathogen to another.
Two  distinct  mechanisms  of  nutrient  deprivation  exist:  (i) 
constitutive mechanisms, such as that mediated by the divalent 
cation transporter Nramp1, present in the membrane of   endosomal 
compartment and participating to iron depletion (Cellier et al., 
2007); and (ii) induced mechanisms, such as those triggered by the 
cytokine IFN-γ in activated macrophages, which may also affect 
iron availability (Mulero and Brock, 1999).
Notably, another pathway triggered by IFN-γ has been shown 
to play a role in the nutritional control of several intracellular 
pathogens (Taylor and Feng, 1991). Activation of the enzyme 
indoleamine 2,3-dioxygenase (ID) which degrades l-tryptophan 
by IFN-γ thus leads to tryptophan deprivation. Monack and co-
workers very recently showed that tryptophan auxotrophs of 
F. tularensis subsp. novicida were severely affected in intracel-
lular survival and multiplication and were attenuated in the 
mouse model (Peng and Monack, 2010). Interestingly, tryp-
tophan metabolism appeared to be important only for bacte-
rial colonization of the lungs, suggesting an organ specificity of 
this metabolic need. The authors found that this antimicrobial 
starvation mechanism mediated by the enzyme ID was effec-
tive against both auxotrophic and prototrophic microbes. These 
observations support the notion that, for bacteria, amino acid 
biosynthesis is more energetically costly than their capture from 
the environment. The necessity to biosynthesize amino acid in 
a depleted environment may thus reduce the capacity of the 
bacterium to replicate.
concluding remarks
Genetic screens have clearly established the critical importance of 
the aromatic amino acids biosynthetic pathway for F. tularensis 
virulence. The fact that inactivation of almost every gene in this 
pathway lead to reduced virulence suggests that the available pool of 
aromatic amino acids is limiting in the infected host. Similarly, the 
severe intracellular growth defect of mutants unable to synthesize 
purines de novo, also suggest that macrophages contain limiting 
concentrations of purines.
Altogether, experimental data and predictive models favor the 
notion that F. tularensis preferentially utilizes specific amino acids 
for energy and fatty acids as gluconeogenic substrates rather than 
carbohydrate sources during cytosolic multiplication. Intracellular 
transcriptomic studies revealed that significant changes occurred in 
the expression of genes encoding enzymes involved in carbohydrate 
metabolism as well as in genes encoding putative amino acid and 
carbohydrate transporters. Hence, the importance of nutrition in 
F. tularensis virulence can be seen as a fine balance between its ability 
to capture nutrients from the host (transport) and the regulation 
of its metabolism in response to the amounts of nutrients available 
(metabolism). Mutations affecting either one or the other (or both) 
of these two functions lead to an impaired fitness and are likely to 
cause a reduced virulence.
Intracellular  pathogens  often  co-regulate  their  metabolic 
needs and the production of dedicated virulence factors by using 
pleiotropic (mainly transcriptional) regulators. The stringent 
response is a stress response that occurs in bacteria in reaction 
to amino acid or carbon starvation. The stringent response is 
signaled by the alarmone ppGpp. Notably, the expression of many 
virulence regulators is mediated by ppGpp, thereby coupling 
pathogenesis to metabolism (Dalebroux et al., 2010). F. tularensis 
also uses ppGpp to control the activity of its major regulator 
of virulence, MglA (Charity et al., 2009). In particular, ppGpp Frontiers in Microbiology  |  Cellular and Infection Microbiology    December 2010  | Volume 1  | Article 140  |  12
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